Lecap Asset Management Ltd. Decreases Holdings in Amdocs Limited (NASDAQ:DOX)

Lecap Asset Management Ltd. trimmed its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 27.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,486 shares of the technology company’s stock after selling 5,154 shares during the quarter. Lecap Asset Management Ltd.’s holdings in Amdocs were worth $1,180,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Pzena Investment Management LLC raised its position in shares of Amdocs by 33.2% during the 2nd quarter. Pzena Investment Management LLC now owns 5,667,603 shares of the technology company’s stock valued at $447,287,000 after buying an additional 1,412,826 shares in the last quarter. LSV Asset Management raised its position in Amdocs by 7.9% in the 2nd quarter. LSV Asset Management now owns 3,207,155 shares of the technology company’s stock worth $253,109,000 after purchasing an additional 234,096 shares during the period. Allspring Global Investments Holdings LLC raised its position in Amdocs by 36.6% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,175,790 shares of the technology company’s stock worth $277,818,000 after purchasing an additional 851,022 shares during the period. Brandes Investment Partners LP raised its position in Amdocs by 31.1% in the 2nd quarter. Brandes Investment Partners LP now owns 2,260,811 shares of the technology company’s stock worth $178,335,000 after purchasing an additional 536,359 shares during the period. Finally, Vanguard Group Inc. raised its position in Amdocs by 39.5% in the 1st quarter. Vanguard Group Inc. now owns 2,033,536 shares of the technology company’s stock worth $183,771,000 after purchasing an additional 576,168 shares during the period. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

Amdocs Price Performance

Shares of DOX stock opened at $89.65 on Thursday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.24 and a quick ratio of 1.24. The company has a market capitalization of $10.54 billion, a P/E ratio of 20.15, a P/E/G ratio of 1.42 and a beta of 0.74. The company’s 50-day simple moving average is $86.86 and its two-hundred day simple moving average is $83.57. Amdocs Limited has a one year low of $74.41 and a one year high of $94.04.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Wednesday, August 7th. The technology company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.02. Amdocs had a net margin of 10.21% and a return on equity of 17.89%. The firm had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.25 billion. During the same period last year, the firm earned $1.41 earnings per share. The company’s quarterly revenue was up 1.1% on a year-over-year basis. As a group, equities analysts anticipate that Amdocs Limited will post 5.67 EPS for the current year.

Amdocs Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a dividend of $0.479 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.14%. Amdocs’s dividend payout ratio is presently 42.92%.

Analyst Upgrades and Downgrades

DOX has been the topic of a number of recent analyst reports. StockNews.com raised shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research report on Thursday, October 10th. Stifel Nicolaus assumed coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Amdocs presently has a consensus rating of “Buy” and an average price target of $102.00.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.